Pharmaceutical and medical innovation
Receive CPI's latest news delivered to your inbox.Sign up to our Mailing List
CPI has extensive multi disciplinary expertise to meet the future demands of the healthcare industry. Working closely with our network of clinical, academic and industrial partners, we help companies translate and validate their products and processes into impactful solutions for the pharmaceutical and medical technology sectors.
Our experience and knowledge spans a wide range of emerging and enabling technologies, including printable electronics, sensors, photonics, nanotechnologies, formulation science, new materials and biotechnology.
The global healthcare and life sciences sectors are in the midst of significant change, presenting both opportunities and challenges for the companies operating within them. This change is driven by supply and demand pressures, patient lifestyle choices, longer life expectancies and a rise in chronic disease.
The UK’s population is predicted to grow from 62.3 million in 2010 to 81.5 million in 2060. The demographics of the population will also change significantly. People are living longer, placing increasing pressure on our health and social care systems to deliver a higher standard of care to more patients.
By closely integrating universities, the clinical research base, industry and the NHS, there is an opportunity to alleviate these pressures through harnessing new technology, innovation and service models. Emerging technologies such as bio-technology, nano-technologies, novel materials, photonics, big data and the internet of things can be utilised to address these challenges.
CPI has extensive experience of working with these collaborative models and emerging technologies, and can provide companies with the facilities and expertise required to commercialise innovative global healthcare solutions.
Conformable electronics and sensors for screening
In-vitro diagnostics (IVD) for biosensors
Sensors integrated into clothing, jewellery and accessories
Medicines based on the body’s own molecules
Light therapies, diagnostics, imaging and surgical intervention
Nanoparticles directly target the source of disease
Advanced pharmaceutical formulation
New approaches to manufacturing medicines
Advanced packaging for tracking, compliance, branding and authentification
New storage and transportation methods for medicinal products